The story of Viagra, originally marketed by copyright, presents a fascinating case study for stakeholders considering the healthcare landscape . Despite its early success and generation of vast in revenue , the exclusivity lapse has opened the floodgates for alternative medications, greatly eroding earnings potential . This transition raises questi